Aptose Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch APTOF and buy or sell other stocks, ETFs, and their options commission-free!About APTOF
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.
CEOWilliam G. Rice
CEOWilliam G. Rice
Employees13
Employees13
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded1986
Founded1986
Employees13
Employees13
APTOF Key Statistics
Market cap4.19M
Market cap4.19M
Price-Earnings ratio-0.20
Price-Earnings ratio-0.20
Dividend yield—
Dividend yield—
Average volume6.10K
Average volume6.10K
High today$1.68
High today$1.68
Low today$1.61
Low today$1.61
Open price$1.62
Open price$1.62
Volume5.90K
Volume5.90K
52 Week high$11.69
52 Week high$11.69
52 Week low$0.6363
52 Week low$0.6363
Stock Snapshot
As of today, Aptose Biosciences(APTOF) shares are valued at $1.64. The company's market cap stands at 4.19M, with a P/E ratio of -0.20.
As of 2025-12-12, Aptose Biosciences(APTOF) stock has fluctuated between $1.61 and $1.68. The current price stands at $1.64, placing the stock +1.9% above today's low and -2.4% off the high.
Aptose Biosciences(APTOF) shares are trading with a volume of 5.9K, against a daily average of 6.1K.
During the past year, Aptose Biosciences(APTOF) stock moved between $0.64 at its lowest and $11.69 at its peak.
During the past year, Aptose Biosciences(APTOF) stock moved between $0.64 at its lowest and $11.69 at its peak.
People also own
Based on the portfolios of people who own APTOF. This list is generated using Robinhood data, and it’s not a recommendation.